Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation

Cancer Research

Volumn 59, Issue 10, 1999, Pages 2335-2339

  Ono, Masaya ^b   Handa, Kazuko ^b   Withers, Donald A ^b   Hakomori, Sen Itiroh ^a  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIMERASE; GENE PRODUCT;

APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; DNA TRANSFECTION; GENE EXPRESSION; HAMSTER; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL MOVEMENT; CHO CELLS; CRICETINAE; CRICETULUS; DNA, COMPLEMENTARY; G(M3) GANGLIOSIDE; GALACTOSE; GLYCOSYLATION; KANGAI-1 PROTEIN; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; TRANSFECTION; UDPGLUCOSE 4-EPIMERASE;

EID: 0033563253     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dong, J-T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAII, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC), 268: 884-886, 1995.
2. Dong, J. T., Suzuki, H., Pin, S. S., Bova, S., Schalken, J. A., Isaacs, W. B., Barrett, J. C., and Isaacs, J. T. Down-regulation of the KAII metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res., 56: 4387-4390, 1996.
3. Miyake, M., Koyama, M., Seno, M., and Ikeyama, S. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med., 174: 1347-1354, 1991.
4. Cajot, J-F., Sordat, I., Silvestre, T., and Sordat, B. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res., 57: 2593-2597, 1997.
5. Adachi, M., Taki, T., Ieki, Y., Huang, C., Higashiyama, M., and Miyake, M. Correlation of KAII/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res., 56: 1751-1755, 1996.
6. Hakomori, S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res., 56: 5309-5318, 1996.
7. Kingsley, D. M., Kozarsky, K. F., Hobbie, L., and Krieger, M. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant. Cell, 44: 749-759, 1986.
8. Krieger, M., Reddy, P., Kozarsky, K., Kingsley, D., Hobbie, L., and Penman, M. Analysis of the synthesis, intracellular sorting, and function of glycoproteins using a mammalian cell mutant with reversible glycosylation defects. Methods Cell Biol., 32: 57-84, 1989.
9. a. Int. J. Oncol., 6: 773-781, 1995.
10. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
11. Ichikawa, D., Handa, K., Withers, D. A., and Hakomori, S. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: approach with A and B gene transfection. Cancer Res., 57: 3092-3096, 1997.
12. Albrecht-Buehler, G. The phagokinetic tracks of 3T3 cells. Cell, 11: 395-404, 1977.
13. Saito, T., and Hakomori, S. Quantitative isolation of total glycosphingolipids from animal cells. J. Lipid Res., 12: 257-259, 1971.
14. Martin, S. J., Green, D. R., and Cotter, T. G. Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem. Sci., 19: 26-30, 1994.
15. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
16. Koopman, G., Reutelingsperger, C. P., Kuijten, G. A., Keehnen, R. M., Pals, S. T., and van Oers, M. H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84: 1415-1420, 1994.
17. Akamatsu, S., Yazawa, S., Zenita, K., Matsumoto, H., Tachikawa, T., and Kannagi, R. Elevation of an α(1,3)fucosyltransferase activity correlated with apoptosis in the human colon adenocarcinoma cell line, HT-29. Glycoconj. J., 13: 1021-1029, 1996.
18. y antigen expression is correlated with apoptosis (programmed cell death). Glycobiology, 3: 381-390, 1993.